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Table I. HLA Antigens with Significantly Elevated Frequencies in Alopecia Areata Patients 
Group Description n 
All patients All patients combined 131 
Group I Newly diagnosed 31 
Group II Long-standing patchy AA 42 
Group III Long-standing AT/AU 58 
1I Pune = P uncorrected. 
b Pear = P corrected by factor of 30 for serologic antigens and 126 for molecular alleles. 
classical serologic methods. For group II patients , there were no 
DRBl alleles found to occur with significantly altered frequencies 
compared with controls when the appropriate correction factor was 
applied to the p values. In group III patients , the most striking 
increase in frequency was that of the DRll subtype, DRB 1 * 11 04, 
which was found in 1 3. 7% (Peor = 6 X 10-13, relative risk = 30.2) 
of group III patients versus 0.5% in controls . A second DR allele, 
DRB1*0401, was increased to 19.6% (Peo, = 0.002) in group III 
patients compared with controls of 6.6%. Group III is also unique in 
the highly significant elevation of frequency of the DQB1 allele, 
DQBl *0301, the molecular equivalent of DQ7, with a frequency 
of 40.2% (Peor = 1.3 X 10-5) compared with 16.0% in controls. 
Both group II and group III show an increase in the frequency of 
DQBl *03 (a combination of the incidence of the three alleles , 
DQB1 *0301, *0302, and *0303): group II frequency is 51.6% (Pem 
= 9.4 X 10-4); group III is 55.9% (Pem = 8.1 X 10-8) compared 
with 24.1 % in controls. Thus, DQB 1 *03 may be a general marker 
allele for alopecia areata. 
A very early age of onset of the first patch of AA was found in 
group III patients : by age 10 years, 45% of patients in group III 
developed their first patch of AA as compared with only 10% of 
group II patients. However, by the age of 40 years the majority of 
both group II and group III patients had their first patch of AA: 96% 
of group III patients and 77% of group II patients. Age of onset also 
correlated with the family history of AA: 37% of patients who 
developed their first patch of AA by age 30 years had family 
members with AA whereas only 7.1% of patients had family 
histories of AA when the first patch appeared after age 30. From all 
these data, it appears that early onset of AA is associated with 
severity of disease, long-standing disease, and familial history of AA. 
We hypo thesize that failure in some previous studies to 
achieve significance for DR and DQ antigens after appropriate 
statistical correction could be due in part to the inappropriate 
grouping of patients or to the conglomeration of all patients into 
Antigen Pune 
a 
Pear 
b 
DQ3 2.0 X 10-8 6.0 X 10-7 
None 
DQ3 1.0 X 10-3 3.0 X 10-2 
DQBl *03 7.4 X 10-6 9.4 X 10-4 
DQ3 2.6 X 10-7 9.0 X 10-6 
DQBl *03 6.4 X 10-10 8.1 X 10-8 
DQB1*0301 1.0 X 10-7 1.3 X 10-5 
DRB1 *0401 2.0 X 10-5 2.0 X 10-3 
DR11 8.0 X 10-5 2.4 X 10-4 
DRB1 *1104 4.8 X 10-15 6.0 X 10-13 
a single study group. In support of this hypothesis, we show that 
a heterogeneous group of newly diagnosed alopecia areata 
patients, group I, fails to show any HLA associations (Pem 
>0.05). When all the patient groups were lumped together for 
analysis ("all patients ") , a significant association was found for 
only a single HLA antigen, DQ3. 
In conclusion, the two clinical forms of alopecia areata, long­
standing AT/AU, and long-standing patchy AA, can be distin­
guished by the singular association of AT/AU patients with the 
HLA class II antigens DRB1 *1104 (DR11) and DQB1 *0301 
(DQ7). These antigens may represent a genetic marker for those 
patients who are more susceptible to severe and long-lasting 
disease. In addition, 79% of all patients showed an association with 
the generic antigen DQBl *03 (DQ3), which may represent a 
generalized susceptibility gene for alopecia areata. 
This work was s"ppO/ted ill pmt by grallts jimn The Upjohn CompallY. 
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6S DUVIC ET AL 
A lopecia areata (AA) has been associated with other autoimmune diseases and is characterized by an inflammatory T-cell infiltrate with the production of cytokines around affected hair follicles. The target for the T cell is at this time unknown. There is a 
wide spectrum of disease actIvIty ranging from one patch of 
alopecia with total regrowth to persistant loss of all scalp and body 
hair. Previous studies by us and by others have suggested that there 
is an association of alopecia areata with genes on chromosome 6 in 
the major histocompatibility locus (HLA). In particular, DR4 and 5 
alleles are increased in unrelated AA patients versus controls [1]. 
Although most cases of alopecia areata occur sporadically , there are 
reports of familial association in 10-47% of affected patients and 
there are cases of discordant and concordant monozygotic twins 
[2]. This suggests that certain genes may be responsible for a genetic 
predisposition for AA and that environmental triggers may also be 
important. The purpose of these studies was to further define the 
immunogenetic basis for AA. 
MATERIALS AND METHODS 
Patients with AA «75% hair loss) or alopecia totalis (AT >75% hair 
loss)/alopecia universalis (AU, total scalp and partial body hair loss) and 
controls signed consents for venopuncture and HLA typing of peripheral 
blood lymphocytes. Individual patients were ascertained from dermatology 
clinic populations. Families were ascertained from the National Alopecia 
Areata Foundation newsletter and were examined by a dermatologist. 
HLA-DR and -DQ alleles were first typed by restriction fragment-length 
polymorphism patterns according to the Eighth International Histocompat­
ibility Workshop [1]. HLA-DR, -DQ, and -DP alleles were ascertained by 
peR amplification and dot blotting with allele-specific oligos according to 
the Eleventh Workshop [3]. Linkage to DQ was by the method of Ott using 
LINKAGE programs [4]. 
RESULTS 
Compared to 78 normal controls, unrelated Caucasian AA patients 
(36 with AA and 50 with AT/AU) had increases in the phenotype 
frequencies ofDR4 and associated DQw8 as well as increases in the 
genotype frequencies of DR4 and DR5 (DRw11). Sixty-one 
percent of all AA patients had DR4 and/or DR5 alleles versus 40% 
of controls. A highly negative association with the DRB3 allele 
DRw52a was also detected [1]. 
In a second study in which allele-specific oligo typing was 
performed in 85 unrelated Caucasian AA patients, there was a 
significant increase in DQB1*301, 41% in all patients, 47% in 
AU/ AT patients, and 27% in controls. Furthermore, DQB1 *301 
alleles (301, 302, 303) were present in 80% of all patients and 92% 
of AT/AU patients (ODDs ratio = 12.14, P = 0.00003, corrected). 
DQB1 *06 was decreased to 32% of all patients versus 56% of 
controls (ODDs ratio = 0.37, P = 0.0045, corrected) . Subtyping of 
DR11 alleles revealed that the DRB1 *1104 allele was found in six 
of seven (86%) DR11 patients with patchy AA (ODDs ratio, 16.25) 
and in five of 13 (55%) AT/AU patients who were DR11, versus 
27% of controls. No association was found with DP alleles or with 
DQA alleles [3]. 
In a third study, we have analyzed 29 multiplex families with 
244 total individuals and 77 affected individuals. Vitiligo, thyroid 
disease, and diabetes were the most commonly reported auto­
immune diseases in these affected individuals and their family 
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members. There were five families with three generations 
affected, three sets of identical twins, one set of fraternal twins, 
and several affected cousins. In two sets of identical twins there 
was discordance for AA. 
We assumed a genetic model of autosomal dominance with 
incomplete penetrance [2], a gene frequency of 1%, a sporadic 
lifetime risk of 0.6%, and a total population susceptibility of 1 %. 
The lifetime penetrance was set at 20% with 10% penetrance by age 
30. Analysis for linkage with DQ in these 29 multiplex families gave 
a positive LOD score of 1.05, with theta = 0.07. This analysis did 
not consider the HLA association in unrelated individuals, which 
would be expected to significantly increase the LOD score. 
CONCLUSIONS 
AA patients have a significant increase in certain HLA-D locus 
antigens compared to race and ethnic matched controls. The 
HLA-DR4 and DR5 [1] alleles previously shown to be associated 
with AA are in linkage disequilibrium with HLA-DQ alleles, which 
are more significantly associated with AA. Among DR11 alleles, 
DR1 *1104 is most significantly associated with patchy AA (ODDs 
ratio = 16). DQB1 *03 alleles are strongly associated with AA and 
AT/AU with an ODDs ratio of 12. These ODDs ratios are 
noteworthy considering values for other autoimmune diseases 
including insulin-dependent diabetes mellitus with DR4 (ODDs 
ratio = 4-6), Celiac disease with DR3 and OR7 (RR = 8-12), and 
pemphigus with DR4 (RR = 24) [3]. 
Whereas disease associations are done in unrelated individuals, 
family studies are necessary to detern�ine whether a particular gene 
is linked to or causes a specific disease. Linkage is a measure of 
recombination frequency between a trait such as AA and a genetic 
locus such as HLA-DQ. These preliminary studies suggest that 
there may be linkage between AA and genes of the DQ locus or its 
neighbors . 
Autoimmune diseases are likely to involve input from several 
different genes, including HLA antigens. It is likely that there are 
environmental factors (drugs, infections, chemicals, etc.) that 
will trigger an autoimmune disease in individuals with the 
proper genetic susceptibility. Other genes are likely to be needed 
to produce the effect and still others to cause disease persistence 
or regression. Because antigen presentation is governed by 
interactions between cells bearing HLA molecules and the T-cell 
receptor, susceptibility genes are likely to involve these specific 
molecules. In particular, we speculate that the proline at position 
55 of the DQB chain shared by the OQB*03 alleles may be 
important for the presentation of an unknown AA-associated 
antigen [3]. Further research to define other associated genes, 
such as the T-cell receptor chains, immunoglobin subtypes, and 
cytokines, is needed to work out the pathogenesis of AA . 
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